Cost-effectiveness of Anticipatory and Preventive multidisciplinary Team Care for complex patients Evidence from a randomized controlled trial

被引:0
|
作者
Gray, David [2 ]
Armstrong, Catherine Deri [2 ,4 ]
Dahrouge, Simone [1 ]
Hogg, William [3 ]
Zhang, Wei [5 ]
机构
[1] Univ Ottawa, Dept Family Med, Elisabeth Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON K1N 5C8, Canada
[2] Univ Ottawa, Dept Econ, Ottawa, ON K1N 6N5, Canada
[3] Univ Ottawa, Dept Family Med, Ottawa, ON K1N 6N5, Canada
[4] Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada
[5] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada
关键词
COGNITIVE-BEHAVIORAL THERAPY;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE To evaluate the cost-effectiveness of Anticipatory and Preventive Team Care (APTCare). DESIGN Analysis of data drawn from a randomized controlled trial. SETTING A family health network in a rural area near Ottawa, Ont. PARTICIPANTS Patients 50 years of age or older at risk of experiencing adverse health outcomes. Analysis of cost-effectiveness was performed for a subsample of participants with at least 1 of the chronic diseases used in the quality of care (QOC) measure ( 74 intervention and 78 control patients). INTERVENTIONS At-risk patients were randomly assigned to receive usual care from their family physicians or APTCare from a collaborative team. MAIN OUTCOME MEASURES Cost-effectiveness and the net benefit to society of the APTCare intervention. RESULTS Costs not directly associated with delivery of the intervention were similar in the 2 arms: $9121 and $9222 for the APTCare and control arms, respectively. Costs directly associated with the program were $3802 per patient for a total cost per patient of $12 923 and $9222, respectively (P=.033). A 1% improvement in QOC was estimated to cost $407 per patient. Analysis of the net benefit to society in absolute dollars found a break-even threshold of $750 when statistical significance was required. This implies that society must place a value of at least $750 on a 1% improvement in QOC in order for the intervention to be socially worthwhile. By any of the metrics used, the APTCare intervention was not cost-effective, at least not in a population for which baseline QOC was high. CONCLUSION Although our calculations suggest that the APTCare intervention was not cost-effective, our results need the following caveats. The costs of such a newly introduced intervention are bound to be higher than those for an established, up-and-running program. Furthermore, it is possible that some benefits of the secondary preventive measures were not captured in this limited 12- to 18-month study or were simply not measured.
引用
收藏
页码:E20 / E29
页数:10
相关论文
共 50 条
  • [41] Cost-Effectiveness of Telemedicine in Remote Orthopedic Consultations: Randomized Controlled Trial
    Buvik, Astrid
    Bergmo, Trine S.
    Bugge, Einar
    Smaabrekke, Arvid
    Wilsgaard, Tom
    Olsen, Jan Abel
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2019, 21 (02)
  • [42] Early intervention in panic: randomized controlled trial and cost-effectiveness analysis
    Meulenbeek, Peter
    Willemse, Godelief
    Smit, Filip
    van Balkom, Anton
    Spinhoven, Philip
    Cuijpers, Pim
    TRIALS, 2008, 9 (1)
  • [43] COST-EFFECTIVENESS OF A RANDOMIZED CONTROLLED TRIAL TO REDUCE FEAR OF CANCER RECURRENCE
    Shih, S. T.
    Butow, P.
    Bowe, S.
    Thewes, B.
    Tunner, J.
    Gilchrist, J.
    Mihalopoulos, C.
    VALUE IN HEALTH, 2018, 21 : S15 - S16
  • [44] Early intervention in panic: randomized controlled trial and cost-effectiveness analysis
    Peter Meulenbeek
    Godelief Willemse
    Filip Smit
    Anton van Balkom
    Philip Spinhoven
    Pim Cuijpers
    Trials, 9
  • [45] Randomized controlled trial on occupational graduated compression clinical and cost-effectiveness
    Gianesini, Sergio
    Vagnoni, Emidia
    Cavicchi, Caterina
    Chi, Yung -Wei
    Pagani, Anselmo
    Tessari, Mirko
    Zamboni, Paolo
    Menegatti, Erica
    INTERNATIONAL ANGIOLOGY, 2023, 42 (04) : 344 - 351
  • [46] Cost-Effectiveness of 2 Models of Pessary Care for Pelvic Organ Prolapse: Findings From the TOPSY Randomized Controlled Trial
    Manoukian, Sarkis
    Mason, Helen
    Hagen, Suzanne
    Kearney, Rohna
    Goodman, Kirsteen
    Best, Catherine
    Elders, Andrew
    Melone, Lynn
    Dwyer, Lucy
    Dembinsky, Melanie
    Khunda, Aethele
    Guerrero, Karen Lesley
    McClurg, Doreen
    Norrie, John
    Thakar, Ranee
    Bugge, Carol
    VALUE IN HEALTH, 2024, 27 (07) : 889 - 896
  • [47] Cost-Effectiveness of Pulmonary Rehabilitation in Patients With Bronchial Asthma: An Analysis of the EPRA Randomized Controlled Trial
    Boeckmann, Denise
    Szentes, Boglarka Lilla
    Schultz, Konrad
    Nowak, Dirk
    Schuler, Michael
    Schwarzkopf, Larissa
    VALUE IN HEALTH, 2021, 24 (09) : 1254 - 1262
  • [48] Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: A cost-effectiveness analysis.
    Laheij, RJF
    Severens, JL
    van de Lisdonk, EH
    Verbeek, ALM
    Jansen, JBMJ
    GASTROENTEROLOGY, 1998, 114 (04) : A191 - A191
  • [49] Cost-Effectiveness of a Community Pharmacist Intervention in Patients with Depression: A Randomized Controlled Trial (PRODEFAR Study)
    Rubio-Valera, Maria
    Bosmans, Judith
    Fernandez, Ana
    Penarrubia-Maria, Maite
    March, Marian
    Trave, Pere
    Bellon, Juan A.
    Serrano-Blanco, Antoni
    PLOS ONE, 2013, 8 (08):
  • [50] Cost-effectiveness of Transforaminal epidural steroid injections for patients with ACUTE sciatica: a randomized controlled trial
    Ter Meulen, Bastiaan C.
    Maas, Esther T.
    van der Vegt, Rien
    Haumann, Johan
    Weinstein, Henry C.
    Ostelo, Raymond W. J. G.
    van Dongen, Johanna M.
    BMC MUSCULOSKELETAL DISORDERS, 2024, 25 (01)